Abbott's fast, $5, 15-minute, easy-to-use COVID-19 antigen test receives FDA Emergency Use Authorization

Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW™ COVID-19 Ag Card rapid test for detection of COVID-19 infection. Abbott will sell this test for $5. It is highly portable (about the size of a credit card), affordable and provides results in 15 minutes.

from Breaking World Pharma News https://ift.tt/2QEZh81